ProShare Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

ProShare Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,002	Closed	-$958K	–	1767
2019 Q4	$958K	Sell	16,002 -1,425	-8%	-$53.5K	﹤0.01%	811
2019 Q3	$490K	Buy	17,427 +550	+3%	+$18.8K	﹤0.01%	992
2019 Q2	$639K	Sell	16,877 -1,665	-9%	-$64K	﹤0.01%	917
2019 Q1	$724K	Buy	18,542 +166	+0.9%	+$4.76K	﹤0.01%	895
2018 Q4	$392K	Sell	18,376 -824	-4%	-$21.3K	﹤0.01%	1035
2018 Q3	$760K	Sell	19,200 -462	-2%	-$17.2K	0.01%	942
2018 Q2	$751K	Buy	19,662 +633	+3%	+$23.4K	0.01%	943
2018 Q1	$572K	Buy	19,029 +508	+3%	+$17.2K	﹤0.01%	1045
2017 Q4	$579K	Buy	18,521 +1,823	+11%	+$50.1K	﹤0.01%	1057
2017 Q3	$468K	Buy	16,698 +1,117	+7%	+$24.3K	﹤0.01%	986
2017 Q2	$298K	Buy	15,581 +3,324	+27%	+$53.1K	﹤0.01%	1172
2017 Q1	$209K	Sell	12,257 -3,020	-20%	-$48.8K	﹤0.01%	1434
2016 Q4	$279K	Buy	+15,277	New	+$264K	﹤0.01%	1417

ProShare Advisors's BOLD Position: Q1 2020 in Review

ProShare Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 16,002 shares — an estimated $958K sold.

ProShare Advisors first reported a position in BOLD in Q4 2016 and held it in 13 quarters. The position peaked at $958K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

ProShare Advisors reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
ProShare Advisors sold 16,002 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $958K.
ProShare Advisors first reported a position in Audentes Therapeutics, Inc in Q4 2016 and held it in 13 quarters.
ProShare Advisors's Audentes Therapeutics, Inc position peaked at $958K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on ProShare Advisors's 13F filing for Q1 2020, filed 15 May 2020.